This chapter will focus on the influence of target organ damage, particularly of left ventricular hypertrophy and subclinical kidney dysfunction, in the choice of ACEIs or ARBs therapy in patients with hypertension and heart failure.
- Dual therapy
- Organ damage
- RAAS blockade
ASJC Scopus subject areas
- Pharmacology, Toxicology and Pharmaceutics(all)